Increasing evidence that the risks of rhAPC may outweigh its benefits. (Q55043389)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Increasing evidence that the risks of rhAPC may outweigh its benefits.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

0 references

Increasing evidence that the risks of rhAPC may outweigh its benefits. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

author name string

Peter Q Eichacker

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

Charles Natanson

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

publication date

15 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

Intensive Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

33

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

396-399

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

The value of phase 4 clinical testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First, gather the data

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a nationwide survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substantiating the concerns about recombinant human activated protein C use in sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00134-007-0556-8

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/17325833

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55043389&oldid=2212638994"